Genomics Stocks 2024: What Investors Need to Know Before the Breakout

The genomics sector has spent years in what feels like a holding pattern—promising revolutionary science, delivering occasional breakthroughs, but struggling to translate laboratory promises into sustained stock performance. If you’ve been watching this space, you already know the tension: the technology is genuinely transformative, but the public markets have been notoriously impatient with companies that […]